Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K
Department of Neurology, Tohoku, University School of Medicine, Sendai, Japan.
J Neurol Sci. 1994 Oct;126(1):77-83. doi: 10.1016/0022-510x(94)90097-3.
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disorder that results in relentless damage to the motor neuron system. Although about 5-10% of cases are familial, the pathophysiologic process of ALS remains unknown. We identified a novel point mutation A to G in exon 2 of the Cu/Zn SOD gene, resulting in an amino acid substitution of histidine46 by arginine (H46R), in two Japanese familial ALS (FALS) families. The segregations of the mutation were evident. The enzymatic activities of Cu/Zn SOD of peripheral red blood cell lysate were reduced to about 80% in the affected members, compared with other non-affected family members. The patients in these families are clinically characterized by relative late onset, initial involvement in lower extremities, relative rare impairment of bulbar muscles and much slow progression of muscular weakness and atrophy, compared with other Japanese FALS cases who have no mutation in the Cu/Zn SOD gene. These findings suggest that the H46R mutation in Cu/Zn SOD gene is highly related to this unique subtype of FALS.
肌萎缩侧索硬化症(ALS)是一种进行性致命性神经疾病,会对运动神经元系统造成持续损害。尽管约5%-10%的病例为家族性,但ALS的病理生理过程仍不清楚。我们在两个日本家族性ALS(FALS)家系中,于铜/锌超氧化物歧化酶(Cu/Zn SOD)基因的第2外显子中鉴定出一个新的A到G的点突变,导致组氨酸46被精氨酸取代(H46R)。该突变的分离情况很明显。与其他未受影响的家族成员相比,受影响成员外周红细胞裂解物中Cu/Zn SOD的酶活性降低至约80%。与其他Cu/Zn SOD基因无突变的日本FALS病例相比,这些家系中的患者临床特征为发病相对较晚、最初累及下肢、延髓肌相对少见受累以及肌无力和萎缩进展缓慢得多。这些发现表明,Cu/Zn SOD基因中的H46R突变与这种独特的FALS亚型高度相关。